 Kelly Knupp
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 25 | 2024 | 122 | 7.540 |
Why?
| | Anticonvulsants | 32 | 2025 | 209 | 6.600 |
Why?
| | Epilepsies, Myoclonic | 26 | 2025 | 45 | 6.440 |
Why?
| | Lennox Gastaut Syndrome | 7 | 2024 | 17 | 3.630 |
Why?
| | Epilepsy | 18 | 2024 | 322 | 3.430 |
Why?
| | Vigabatrin | 9 | 2022 | 18 | 2.650 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2020 | 133 | 2.460 |
Why?
| | Seizures | 26 | 2025 | 401 | 2.000 |
Why?
| | Electroencephalography | 12 | 2024 | 399 | 1.840 |
Why?
| | Drug Resistant Epilepsy | 8 | 2025 | 82 | 1.670 |
Why?
| | Epilepsies, Partial | 4 | 2025 | 44 | 1.380 |
Why?
| | Epilepsy, Generalized | 3 | 2023 | 17 | 1.170 |
Why?
| | Fenfluramine | 8 | 2024 | 14 | 1.110 |
Why?
| | Glucocorticoids | 3 | 2020 | 578 | 1.070 |
Why?
| | Delphi Technique | 3 | 2024 | 225 | 1.060 |
Why?
| | Infant | 32 | 2025 | 8975 | 0.930 |
Why?
| | Plant Extracts | 4 | 2020 | 198 | 0.920 |
Why?
| | Cannabidiol | 4 | 2022 | 108 | 0.920 |
Why?
| | NAV1.6 Voltage-Gated Sodium Channel | 1 | 2024 | 10 | 0.910 |
Why?
| | Prednisolone | 4 | 2020 | 82 | 0.870 |
Why?
| | Developmental Disabilities | 4 | 2020 | 261 | 0.830 |
Why?
| | Status Epilepticus | 5 | 2024 | 42 | 0.830 |
Why?
| | Genetic Therapy | 2 | 2023 | 288 | 0.820 |
Why?
| | Sleep | 4 | 2024 | 684 | 0.730 |
Why?
| | Child | 43 | 2025 | 20785 | 0.730 |
Why?
| | Child, Preschool | 26 | 2025 | 10459 | 0.720 |
Why?
| | Medical Marijuana | 2 | 2019 | 111 | 0.700 |
Why?
| | Dioxolanes | 2 | 2020 | 6 | 0.680 |
Why?
| | Humans | 80 | 2025 | 129266 | 0.670 |
Why?
| | Caregivers | 6 | 2025 | 809 | 0.570 |
Why?
| | Leukomalacia, Periventricular | 1 | 2017 | 7 | 0.560 |
Why?
| | Precision Medicine | 1 | 2021 | 386 | 0.560 |
Why?
| | Thyrotropin | 1 | 2017 | 109 | 0.550 |
Why?
| | Treatment Outcome | 17 | 2025 | 10202 | 0.520 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.510 |
Why?
| | Cannabis | 3 | 2020 | 463 | 0.490 |
Why?
| | Male | 44 | 2025 | 63512 | 0.490 |
Why?
| | Treatment Failure | 1 | 2016 | 339 | 0.480 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 307 | 0.480 |
Why?
| | Adolescent | 24 | 2025 | 20313 | 0.460 |
Why?
| | Perception | 1 | 2017 | 337 | 0.460 |
Why?
| | Female | 44 | 2025 | 68551 | 0.450 |
Why?
| | Unverricht-Lundborg Syndrome | 1 | 2014 | 1 | 0.440 |
Why?
| | Lafora Disease | 1 | 2014 | 2 | 0.440 |
Why?
| | Testosterone | 1 | 2017 | 372 | 0.440 |
Why?
| | Disease Progression | 2 | 2021 | 2630 | 0.430 |
Why?
| | Migraine Disorders | 2 | 2024 | 101 | 0.430 |
Why?
| | Epilepsy, Absence | 2 | 2023 | 8 | 0.420 |
Why?
| | Myoclonus | 2 | 2023 | 13 | 0.420 |
Why?
| | Administration, Oral | 5 | 2019 | 785 | 0.420 |
Why?
| | Physicians | 1 | 2021 | 859 | 0.410 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1497 | 0.410 |
Why?
| | Adrenal Cortex Hormones | 1 | 2016 | 522 | 0.390 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 4 | 2023 | 15 | 0.370 |
Why?
| | Cost of Illness | 3 | 2018 | 277 | 0.360 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 339 | 0.360 |
Why?
| | Coronavirus Infections | 3 | 2020 | 333 | 0.360 |
Why?
| | Prospective Studies | 11 | 2023 | 7123 | 0.350 |
Why?
| | Retrospective Studies | 14 | 2025 | 14461 | 0.350 |
Why?
| | Hypertension | 1 | 2019 | 1242 | 0.350 |
Why?
| | Parents | 3 | 2022 | 1309 | 0.350 |
Why?
| | Epileptic Syndromes | 4 | 2024 | 80 | 0.330 |
Why?
| | Dronabinol | 3 | 2022 | 203 | 0.310 |
Why?
| | Pandemics | 4 | 2022 | 1481 | 0.310 |
Why?
| | Consensus | 4 | 2024 | 615 | 0.310 |
Why?
| | Executive Function | 2 | 2024 | 431 | 0.300 |
Why?
| | Cannabinoids | 2 | 2022 | 153 | 0.290 |
Why?
| | Genetic Testing | 2 | 2023 | 428 | 0.280 |
Why?
| | Cohort Studies | 7 | 2024 | 5409 | 0.270 |
Why?
| | Biological Ontologies | 1 | 2025 | 17 | 0.240 |
Why?
| | Diet, Ketogenic | 1 | 2025 | 36 | 0.240 |
Why?
| | Headache | 1 | 2006 | 151 | 0.240 |
Why?
| | Seizures, Febrile | 1 | 2024 | 22 | 0.230 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 8 | 0.230 |
Why?
| | Delivery of Health Care | 3 | 2020 | 892 | 0.230 |
Why?
| | Vagus Nerve Stimulation | 1 | 2024 | 30 | 0.230 |
Why?
| | Analgesics | 1 | 2006 | 189 | 0.230 |
Why?
| | Acidosis, Lactic | 1 | 2024 | 46 | 0.220 |
Why?
| | Natural Language Processing | 1 | 2025 | 94 | 0.220 |
Why?
| | Epilepsy, Reflex | 1 | 2023 | 1 | 0.210 |
Why?
| | Comorbidity | 2 | 2019 | 1544 | 0.210 |
Why?
| | Betacoronavirus | 3 | 2020 | 248 | 0.210 |
Why?
| | Video Recording | 1 | 2024 | 163 | 0.210 |
Why?
| | Young Adult | 8 | 2025 | 12391 | 0.210 |
Why?
| | Wakefulness | 1 | 2024 | 120 | 0.210 |
Why?
| | Family | 2 | 2018 | 644 | 0.210 |
Why?
| | Neuropsychological Tests | 2 | 2025 | 1014 | 0.210 |
Why?
| | Double-Blind Method | 3 | 2022 | 1875 | 0.200 |
Why?
| | Quality of Life | 4 | 2024 | 2687 | 0.200 |
Why?
| | Cosyntropin | 1 | 2022 | 4 | 0.190 |
Why?
| | Spasm | 1 | 2022 | 20 | 0.190 |
Why?
| | Outpatients | 1 | 2025 | 367 | 0.190 |
Why?
| | Sodium Channel Blockers | 1 | 2021 | 24 | 0.190 |
Why?
| | Benzazepines | 2 | 2018 | 39 | 0.180 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 78 | 0.180 |
Why?
| | Oligonucleotides, Antisense | 1 | 2021 | 113 | 0.180 |
Why?
| | Dependovirus | 1 | 2021 | 62 | 0.180 |
Why?
| | Shab Potassium Channels | 1 | 2020 | 18 | 0.170 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2020 | 9 | 0.170 |
Why?
| | Machine Learning | 1 | 2025 | 442 | 0.170 |
Why?
| | Infant, Newborn | 7 | 2024 | 5736 | 0.170 |
Why?
| | Cognition | 2 | 2025 | 1122 | 0.170 |
Why?
| | Adult | 10 | 2025 | 35495 | 0.160 |
Why?
| | Standard of Care | 1 | 2020 | 71 | 0.160 |
Why?
| | Internationality | 1 | 2020 | 149 | 0.160 |
Why?
| | Causality | 1 | 2019 | 118 | 0.160 |
Why?
| | Hormones | 1 | 2019 | 140 | 0.160 |
Why?
| | Eyelids | 3 | 2023 | 34 | 0.150 |
Why?
| | Mutation | 3 | 2023 | 3710 | 0.150 |
Why?
| | Tandem Mass Spectrometry | 2 | 2022 | 523 | 0.150 |
Why?
| | Drug Approval | 1 | 2019 | 87 | 0.150 |
Why?
| | Health Surveys | 2 | 2018 | 493 | 0.150 |
Why?
| | Phenobarbital | 1 | 2018 | 19 | 0.150 |
Why?
| | Health Care Surveys | 1 | 2020 | 557 | 0.150 |
Why?
| | Animals | 6 | 2021 | 35309 | 0.150 |
Why?
| | United States | 7 | 2019 | 13826 | 0.140 |
Why?
| | Sickness Impact Profile | 1 | 2018 | 55 | 0.140 |
Why?
| | Incidence | 2 | 2019 | 2636 | 0.140 |
Why?
| | Urine | 1 | 2017 | 60 | 0.140 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 7 | 0.140 |
Why?
| | Body Height | 1 | 2017 | 192 | 0.130 |
Why?
| | Surveys and Questionnaires | 4 | 2021 | 5384 | 0.130 |
Why?
| | Brain | 3 | 2018 | 2669 | 0.130 |
Why?
| | Heterozygote | 1 | 2017 | 272 | 0.130 |
Why?
| | Employment | 1 | 2018 | 167 | 0.130 |
Why?
| | Neuroimaging | 1 | 2018 | 278 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 205 | 0.120 |
Why?
| | Benzimidazoles | 1 | 2017 | 162 | 0.120 |
Why?
| | Intellectual Disability | 1 | 2017 | 154 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1199 | 0.120 |
Why?
| | Health Care Costs | 1 | 2018 | 367 | 0.120 |
Why?
| | Telemedicine | 2 | 2020 | 788 | 0.120 |
Why?
| | Serotonin | 1 | 2017 | 318 | 0.110 |
Why?
| | Neurology | 3 | 2020 | 102 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2017 | 252 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 851 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2018 | 526 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4887 | 0.110 |
Why?
| | Neurosurgical Procedures | 1 | 2015 | 166 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 939 | 0.100 |
Why?
| | Infant, Premature | 1 | 2017 | 541 | 0.100 |
Why?
| | Colorado | 2 | 2019 | 4406 | 0.100 |
Why?
| | Pentobarbital | 1 | 2011 | 16 | 0.100 |
Why?
| | Communication | 3 | 2024 | 836 | 0.100 |
Why?
| | Age of Onset | 3 | 2018 | 496 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 757 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 685 | 0.090 |
Why?
| | Observational Studies as Topic | 2 | 2024 | 110 | 0.090 |
Why?
| | Neurologists | 2 | 2021 | 20 | 0.090 |
Why?
| | Research Design | 1 | 2017 | 1043 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 637 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1896 | 0.090 |
Why?
| | Piracetam | 1 | 2010 | 13 | 0.090 |
Why?
| | Hypnotics and Sedatives | 1 | 2011 | 175 | 0.080 |
Why?
| | Limit of Detection | 2 | 2022 | 82 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2553 | 0.080 |
Why?
| | Forecasting | 2 | 2024 | 359 | 0.080 |
Why?
| | Health Resources | 2 | 2020 | 113 | 0.070 |
Why?
| | Middle Aged | 6 | 2025 | 31090 | 0.070 |
Why?
| | Drug Therapy, Combination | 2 | 2020 | 1040 | 0.060 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2005 | 55 | 0.060 |
Why?
| | Maternal Behavior | 1 | 2005 | 74 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.060 |
Why?
| | Oxytocin | 1 | 2005 | 48 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1497 | 0.060 |
Why?
| | Disease Management | 2 | 2020 | 588 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1432 | 0.060 |
Why?
| | Rare Diseases | 1 | 2025 | 99 | 0.060 |
Why?
| | Heredodegenerative Disorders, Nervous System | 1 | 2004 | 2 | 0.060 |
Why?
| | Intranuclear Inclusion Bodies | 1 | 2004 | 3 | 0.060 |
Why?
| | Hyalin | 1 | 2004 | 6 | 0.060 |
Why?
| | Wechsler Scales | 1 | 2024 | 53 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2015 | 2473 | 0.050 |
Why?
| | Syncope | 1 | 2024 | 51 | 0.050 |
Why?
| | Introns | 1 | 2024 | 251 | 0.050 |
Why?
| | Signal Transduction | 1 | 2017 | 4926 | 0.050 |
Why?
| | Aggression | 1 | 2005 | 199 | 0.050 |
Why?
| | Rectum | 1 | 2004 | 170 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2020 | 3386 | 0.050 |
Why?
| | Pediatrics | 2 | 2020 | 1049 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 9745 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2024 | 705 | 0.050 |
Why?
| | Eosinophils | 1 | 2004 | 324 | 0.050 |
Why?
| | Inpatients | 1 | 2025 | 462 | 0.040 |
Why?
| | Health Services | 1 | 2021 | 99 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2025 | 614 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 424 | 0.040 |
Why?
| | Internet | 1 | 2024 | 615 | 0.040 |
Why?
| | Videoconferencing | 1 | 2020 | 64 | 0.040 |
Why?
| | Tuberous Sclerosis | 1 | 2020 | 48 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 201 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5050 | 0.040 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 117 | 0.040 |
Why?
| | Half-Life | 1 | 2019 | 162 | 0.040 |
Why?
| | Biological Availability | 1 | 2019 | 147 | 0.040 |
Why?
| | Pediatricians | 1 | 2020 | 129 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2004 | 589 | 0.040 |
Why?
| | Critical Illness | 1 | 2024 | 757 | 0.040 |
Why?
| | Drug Resistance | 1 | 2019 | 166 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 315 | 0.040 |
Why?
| | Qualitative Research | 1 | 2025 | 1215 | 0.040 |
Why?
| | Neurologic Examination | 2 | 2011 | 114 | 0.040 |
Why?
| | Gene Ontology | 1 | 2018 | 49 | 0.040 |
Why?
| | Preexisting Condition Coverage | 1 | 2017 | 3 | 0.040 |
Why?
| | Proteomics | 1 | 2024 | 1054 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 23 | 0.040 |
Why?
| | Waiting Lists | 1 | 2019 | 237 | 0.040 |
Why?
| | Global Health | 1 | 2020 | 327 | 0.040 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2017 | 12 | 0.030 |
Why?
| | Efficiency | 1 | 2018 | 91 | 0.030 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2017 | 22 | 0.030 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 32 | 0.030 |
Why?
| | Medicaid | 1 | 2021 | 431 | 0.030 |
Why?
| | Receptors, Serotonin | 1 | 2017 | 33 | 0.030 |
Why?
| | Drug Costs | 1 | 2018 | 100 | 0.030 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2017 | 69 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2017 | 104 | 0.030 |
Why?
| | Income | 1 | 2018 | 188 | 0.030 |
Why?
| | Microcephaly | 1 | 2017 | 87 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2017 | 228 | 0.030 |
Why?
| | Larva | 1 | 2017 | 214 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2018 | 247 | 0.030 |
Why?
| | RNA Splicing | 1 | 2017 | 260 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 580 | 0.030 |
Why?
| | Central Nervous System | 1 | 2017 | 253 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 874 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 286 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1347 | 0.030 |
Why?
| | Zebrafish | 1 | 2017 | 458 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 820 | 0.020 |
Why?
| | Genetic Variation | 1 | 2017 | 938 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 1965 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3773 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2120 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2011 | 399 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2010 | 202 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 768 | 0.020 |
Why?
| | Kidney | 1 | 2017 | 1385 | 0.020 |
Why?
| | Depression | 1 | 2018 | 1306 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2276 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3074 | 0.020 |
Why?
| | Hospitalization | 1 | 2018 | 2052 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2879 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 978 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4057 | 0.020 |
Why?
| | Nalidixic Acid | 1 | 2005 | 1 | 0.020 |
Why?
| | Naphthyridines | 1 | 2005 | 16 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2515 | 0.020 |
Why?
| | Fluoxetine | 1 | 2005 | 52 | 0.010 |
Why?
| | Drug Synergism | 1 | 2005 | 370 | 0.010 |
Why?
| | Submucous Plexus | 1 | 2004 | 2 | 0.010 |
Why?
| | Myenteric Plexus | 1 | 2004 | 4 | 0.010 |
Why?
| | Consanguinity | 1 | 2004 | 47 | 0.010 |
Why?
| | Aged | 1 | 2022 | 22032 | 0.010 |
Why?
| | Postpartum Period | 1 | 2005 | 332 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2005 | 506 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2011 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1092 | 0.010 |
Why?
| | Ultrasonography | 1 | 2004 | 713 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2396 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6543 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5482 | 0.010 |
Why?
| | Neurons | 1 | 2004 | 1494 | 0.010 |
Why?
| | Pregnancy | 1 | 2005 | 6390 | 0.010 |
Why?
|
|
Knupp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|